Clinical Trials Browser

Phase 1 × Hemangioendothelioma, Epithelioid × Clear all

NCT05228015 2024-11-18

Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects with Advanced Solid Tumors

Phase 1 Terminated

Other solid neoplasmThoracic

Mesothelioma, Malignant, Hemangioendothelioma, Epithelioid

NCT06452160 2024-08-09

A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasmThoracic

Mesothelioma, Hemangioendothelioma, Epithelioid